Provider review
Rivo Health review
Halves every price under a limited-time banner, and prints the standing rate beside it.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$114/mo sema at half price, $228/mo standing
Visit Rivo HealthThe pre-discount figure is shown rather than implied, so what the price reverts to is visible — the one thing a limited-time headline usually hides. What is not published is the date the reversion happens.
Price as published
Rivo Health
$114/mo sema at half price, $228/mo standing
- Vs median
- $61/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Almost every seller running a countdown prints the discounted number and leaves you to discover the other one later. This one prints both, side by side, across its injectable and oral options — semaglutide at half rate with the standing figure right beside it. That is how a promotion should be shown, and it is uncommon enough here to be the main reason to take the site seriously. The gap is the calendar. Nothing published says when the offer ends, so you can see the rate you will eventually pay without knowing when you start paying it, and on a treatment measured in months that is most of the budgeting question. Two smaller things. The savings advertised on longer supplies are calculated against the undiscounted rate rather than the one actually on offer, so they read considerably larger than the choice in front of you. And every injectable figure is a "starting at" with no dose published behind it — so the low number is a floor of unstated depth rather than the price of a small dose, which for anyone planning to hold low is the difference that matters.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to see what the price reverts to before committing to a discounted rate.
- You want an oral option priced alongside the injectable rather than quoted separately.
- You want multi-month discounts applied automatically instead of hunting for a code.
Look elsewhere if
- You need to know when the discount ends. No date is published anywhere.
- You are pricing a low dose. Every figure is a starting point with no dose behind it.
- You take advertised savings at face value. They are quoted against the undiscounted rate.
What it actually costs
Price as published
$114/mo sema at half price, $228/mo standing
- Vs median
- $61/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Semaglutide is priced at half rate with the standing figure printed beside it, so both numbers are readable before intake. Oral options are priced too. No low-dose product is sold, and every injectable figure is a "starting at" with no dose behind it, so the floor is not a low-dose rate — it is a floor of unstated depth inside a standard plan.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Prints the standing rate beside the discounted one, so what the price reverts to is visible.
- Publishes oral options with their own figures rather than injectables alone.
- Multi-month discounts are applied automatically rather than requiring a code.
Pharmacy, labs and oversight
Rivo Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Rivo Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Most sellers running a limited-time headline print the discounted figure and leave the reader to wonder what it reverts to. Rivo Health prints both. Semaglutide is half price against a standing figure shown right beside it, and the same pairing runs across its oral options. That is the honest way to run a promotion, and it is rare enough here to be the main reason to look. What is missing is the date. Nothing says when the offer ends, so a reader can see the rate they will eventually pay but not when they will start paying it — and on a treatment measured in months rather than weeks, that gap is the whole budgeting question. The savings figures attached to longer supplies are quoted against the undiscounted rate rather than the one a reader is being offered, so they read larger than the choice actually is. And every injectable price is a "starting at" with no dose published behind it, which means the low end of the range is a floor of unstated depth rather than the price of a low dose.
The honest cons
No end date is published for the discount, so when the standing rate begins is unknown.
- Savings figures are quoted against the undiscounted rate, which makes them read larger than the actual choice.
- Every injectable price is "starting at" with no dose published behind it.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Rivo Health is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Rivo Health does. Both are partners: we may earn a commission if you start care through these links.
Partner
Strut Health
$99/mo sema lozenge (auto-refill)
Standard plan, self-directed low dose
FDA warning letter · Strut Health · February 2026 · addressed to Strut Health, LLC dba Strut. Details in our review.
Partner
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
Standard plan, self-directed low dose
Where this sits
#176 of 548
Ordered with the companies that pay us first, and Rivo Health is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Oral semaglutide (Rybelsus)
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Direct Meds
From $249/mo sublingual · $297/mo injection
FDA warning letter · Direct Meds · September 2025 · addressed to directmeds.com, Inc. dba DirectMeds. Details in our review.
- Vs median
- $74/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by CraftedRx · ChemistryRx
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Direct Meds review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.